Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenPath provides advanced clinical diagnostic testing services with a focus on oncology. Its portfolio includes next-generation sequencing-based tests for both hematologic malignancies and solid tumors. Proprietary offerings like the OnkoMatch™, developed with Massachusetts General Hospital for comprehensive solid tumor genotyping nationwide access to personalized therapy selection. The company also offers specialized urology diagnostics such as the widely used prostate biomarker test—the 4Kscore Test®. Their clinical team includes board-certified pathologists specializing in various subfields of pathology. They have received industry recognition such as Frost & Sullivan's Clinical Diagnostics Company of the Year Award.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenPath Diagnostics.